+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Chronic Spontaneous Urticaria- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Keloid- Pipeline Insight, 2025 - Product Thumbnail Image

Keloid- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Necrobiosis Lipoidica - Pipeline Insight, 2025 - Product Thumbnail Image

Necrobiosis Lipoidica - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Radiodermatitis- - Pipeline Insight, 2025 - Product Thumbnail Image

Radiodermatitis- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Netherton Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Netherton Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Seborrhoeic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Seborrhoeic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Palmoplantar Pustulosis - Pipeline Insight, 2025 - Product Thumbnail Image

Palmoplantar Pustulosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Palmoplantar Keratoderma - Pipeline Insight, 2025 - Product Thumbnail Image

Palmoplantar Keratoderma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Scleroderma - Pipeline Insight, 2025 - Product Thumbnail Image

Scleroderma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Chronic Hand Eczema - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hand Eczema - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Uremic Pruritus - Pipeline Insight, 2025 - Product Thumbnail Image

Uremic Pruritus - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acne - Pipeline Insight, 2025 - Product Thumbnail Image

Acne - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acne Vulgaris - Epidemiology Forecast - 2034 - Product Thumbnail Image

Acne Vulgaris - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 119 Pages
  • Global
From
DUPIXENT Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

DUPIXENT Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Epidermolysis Bullosa - Epidemiology Forecast - 2034 - Product Thumbnail Image

Epidermolysis Bullosa - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 91 Pages
  • Global
From
Etanercept - Biosimilar Insight, 2024 - Product Thumbnail Image

Etanercept - Biosimilar Insight, 2024

  • Report
  • August 2024
  • 60 Pages
  • Global
From
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more